|Sign up to automatically receive the weekly TTB Newsletter (via email).|
TTB NEWSLETTER | Weekly News
November 20, 2015
IN THIS ISSUE
Greetings! We hope you had a resilient and robust week! This week's top stories include a reminder to file operational reports on time, Formulas Online 2.0 release, FDA proposed rule on “gluten free” claim, and a list of the past week's top advertising pages at TTB.gov/.
WHAT'S POPULAR ON TTB.gov/
Top Advertising Pages for Nov 9 – 15, 2015
ABOUT THE NEWSLETTER
The TTB Newsletter compiles the top TTB news of the week and other helpful information about the Bureau and the federal alcohol and tobacco laws and regulations we enforce.
Please send any questions or comments to the Executive Liaison for Industry and State Matters at Industry-StateLiaison@ttb.gov/.
Brought to you by TTB.gov/.
Want BIG text? Learn how!
OPERATIONAL REPORTS MUST BE FILED ON TIME – KNOW YOUR DUE DATES
We did a recent analysis, which shows that many industry members who are required to file operational reports do not file them on time in compliance with federal regulations. Failure to file required operational reports by the due date is a violation of the conditions of your permit and can lead to adverse action.
We'd like to take this opportunity to remind members of the wine, beer, distilled spirits, and tobacco industries who are subject to operational report filing requirements of the due dates for these reports:
FILING TIP: We have noticed that industry members who file their operational reports via Pay.gov/ have a better record of filing on time!
INTRODUCING FORMULAS ONLINE 2.0
On Friday, November 20, 2015, we released Formulas Online version 2.0. Our goals are to improve your user experience and help you perfect your application, so please take a look at some of the highlights of this new release:
Beverage Alcohol Formula Users:
FDA RELEASES PROPOSED RULE TO ESTABLISH “GLUTEN-FREE” LABELING COMPLIANCE REQUIREMENTS FOR FERMENTED, HYDROLYZED AND DISTILLED FOODS
The FDA announced that it is soliciting comments on a proposed rule to establish requirements for fermented and hydrolyzed foods, or foods that contain fermented or hydrolyzed ingredients, and bear a “gluten-free” claim. TTB’s current policy on “gluten-free” label claims on alcohol beverage labels can be found in TTB Ruling 2014-2.
Source: FDA Constituent Update
November 17, 2015
The U.S. Food and Drug Administration today released a proposed rule to establish requirements for fermented and hydrolyzed foods, or foods that contain fermented or hydrolyzed ingredients, and bear the “gluten-free” claim. The proposed rule, titled “Gluten-Free Labeling of Fermented or Hydrolyzed Foods,” pertains to foods such as yogurt, sauerkraut, pickles, cheese, green olives, vinegar, and FDA regulated beers.
In 2013, the FDA issued the gluten-free final rule, which addressed the uncertainty in interpreting the results of current gluten test methods for fermented and hydrolyzed foods in terms of intact gluten. Due to this uncertainty, the FDA has issued this proposed rule to provide alternative means for the agency to verify compliance for fermented or hydrolyzed foods labeled “gluten-free” based on records that are made and kept by the manufacturer.
The proposed rule, when finalized, would require these manufacturers to make and keep records demonstrating assurance that:
Distilled foods such as distilled vinegars are also included in the proposed rule. Distillation is a purification process that separates volatile components from non-volatile components such as proteins. Thus, when properly done, gluten should not be present in distilled foods. The proposed rule states that FDA would evaluate compliance of distilled foods by verifying the absence of protein (including gluten) using scientifically valid analytical methods that can detect the presence of protein or protein fragments in the distilled food.
The FDA is accepting public comments beginning Wednesday, November 18. To electronically submit comments to the docket, visit www.regulations.gov/ and type docket number “FDA-2014-N-1021” in the search box.
To submit comments to the docket by mail, use the following address. Be sure to include docket number “FDA-2014-N-1021” on each page of your written comments.
Division of Dockets Management
For more information: